{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:50:28Z","timestamp":1793854228948,"version":"4.6.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:title>Graphical Abstract<\/jats:title><jats:p><jats:fig><jats:caption><jats:p>Interactions and correlations between metabolites, pancreatic hormones, and growth factors. Note the gender differences, frequently opposite among metabolites, insulin and glucagon with growth factors, as well as the effect of metabolic disturbances induced by Diabetes type 2. The size of the arrows indicates the strength of the correlation and the direction whether the correlation was straight or inverse.<\/jats:p><\/jats:caption><\/jats:fig><\/jats:p>","DOI":"10.3389\/fmolb.2024.1362305","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T07:04:35Z","timestamp":1713164675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Gender effect of glucose, insulin\/glucagon ratio, lipids, and nitrogen-metabolites on serum HGF and EGF levels in patients with diabetes type 2"],"prefix":"10.3389","volume":"11","author":[{"given":"Martha Lucinda","family":"Contreras-Zentella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Gabriela","family":"Alatriste-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Su\u00e1rez-Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Hern\u00e1ndez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.mayocpiqo.2020.02.001","article-title":"Hormonal contribution to liver regeneration","volume":"4","author":"Abu Rmilah","year":"2020","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5681\/bi.2013.008","article-title":"The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction","volume":"3","author":"Akhtar","year":"2013","journal-title":"Bioimpacts"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1210\/en.2012-1496","article-title":"Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms","volume":"153","author":"Ara\u00fajo","year":"2012","journal-title":"Endocrinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1432-1033.1984.tb08240.x","article-title":"Regulation of peripheral insulin\/glucagon levels by rat liver","volume":"141","author":"Balks","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1158\/0008-5472.CAN-12-3775","article-title":"EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis","volume":"73","author":"Breindel","year":"2013","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1137\/070710111","article-title":"Power-law distributions in empirical data","volume":"51","author":"Clauset","year":"2009","journal-title":"SIAM Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0219481","DOI":"10.1371\/journal.pone.0219481","article-title":"The role of oxidant stress and gender in the erythrocyte arginine metabolism and ammonia management in patients with type 2 diabetes","volume":"14","author":"Contreras-Zentella","year":"2019","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s0002-9440(10)62987-2","article-title":"Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance","volume":"167","author":"Dai","year":"2005","journal-title":"Am. J. Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/joe.0.1350059","article-title":"Growth hormone promotes early initiation of hepatocyte growth factor gene expression in the liver of hypophysectomized rats after partial hepatectomy","volume":"135","author":"Ekberg","year":"1992","journal-title":"J. Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/nm.2531","article-title":"A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism","volume":"17","author":"Fafalios","year":"2011","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-SS051","article-title":"Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules","volume":"4","author":"Fay","year":"2010","journal-title":"Stat. Surv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"New Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1517\/14728222.2016.1162293","article-title":"Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair","volume":"20","author":"Frisch","year":"2016","journal-title":"Expert. Opin. Ther. Targets"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-16-0951","article-title":"HGF\/Met signaling in head and neck cancer: impact on the tumor microenvironment","volume":"22","author":"Hartmann","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000094533","article-title":"Does epidermal growth factor participate in the regulation of glucose, insulin and glucagon levels?","volume":"38","author":"Jansen","year":"2006","journal-title":"Eur. Surg. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1634\/stemcells.2006-0761","article-title":"Generation of insulin-producing islet-like clusters from human embryonic stem cells","volume":"25","author":"Jiang","year":"2007","journal-title":"Stem Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.3748\/wjg.v22.i19.4638","article-title":"Recent updates of precision therapy for gastric cancer: towards optimal tailored management","volume":"22","author":"Joo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/cancers6041890","article-title":"Mechanisms of hepatocyte growth factor activation in cancer tissues","volume":"6","author":"Kawaguchi","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4239\/wjd.v5.i5.678","article-title":"Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus","volume":"5","author":"Konya","year":"2014","journal-title":"World J. Diabetes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1677\/joe.0.1620167","article-title":"Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes","volume":"162","author":"Krakowski","year":"1999","journal-title":"J. Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jhep.2014.05.019","article-title":"Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice","volume":"61","author":"Kroy","year":"2014","journal-title":"J. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23418","DOI":"10.3390\/ijms151223418","article-title":"Recent developments in \u03b2-cell differentiation of pluripotent stem cells induced by small and large molecules","volume":"15","author":"Kumar","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/hr.2014.41","article-title":"Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes","volume":"37","author":"Kusunoki","year":"2014","journal-title":"Hypertens. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3945\/an.113.005488","article-title":"Pancreatic \u03b2-cell proliferation in obesity","volume":"5","author":"Linnemann","year":"2014","journal-title":"Adv. Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann. Math. Stat."},{"key":"B27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.bbadis.2012.02.012","article-title":"Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways","volume":"1822","author":"Marquardt","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"B28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2337\/db09-1305","article-title":"Disruption of hepatocyte growth factor\/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes","volume":"60","author":"Mellado-Gil","year":"2011","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1097\/00004872-199816121-00025","article-title":"Hepatocyte growth factor as a potential index of complication in diabetes mellitus","volume":"16","author":"Nakamura","year":"1998","journal-title":"J. Hypertens."},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0955-2235(91)90014-u","article-title":"Structure and function of hepatocyte growth factor","volume":"3","author":"Nakamura","year":"1991","journal-title":"Prog. Growth Factor Res."},{"key":"B31","first-page":"501","article-title":"Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET","volume":"6","author":"Naldini","year":"1991","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.4049\/jimmunol.175.7.4745","article-title":"A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function","volume":"175","author":"Okunishi","year":"2005","journal-title":"J. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fendo.2018.00503","article-title":"The role of hepatocyte growth factor (HGF) in insulin resistance and diabetes","volume":"9","author":"Oliveira","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1210\/endo.137.7.8770939","article-title":"A role for hepatocyte growth factor\/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth","volume":"137","author":"Otonkoski","year":"1996","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e66823","DOI":"10.1371\/journal.pone.0066823","article-title":"Increased erythrocytes by-products of arginine catabolism are associated with hyperglycemia and could be involved in the pathogenesis of type 2 diabetes mellitus","volume":"8","author":"Ram\u00edrez-Zamora","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/cancers7030861","article-title":"Hepatocyte growth factor from a clinical perspective: a pancreatic cancer challenge","volume":"7","author":"Rizwani","year":"2015","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"739428","DOI":"10.1155\/2012\/739428","article-title":"Central role of the EGF receptor in neurometabolic aging","volume":"2012","author":"Siddiqui","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a001111","article-title":"Hepatocyte growth factor as indicator for subclinical atherosclerosis","volume":"2024","author":"Sommer","year":"2024","journal-title":"Vasa"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0140148","DOI":"10.1371\/journal.pone.0140148","article-title":"Beta cell mass restoration in alloxan-Diabetic mice treated with EGF and gastrin","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1210\/jc.2004-0761","article-title":"Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass","volume":"90","author":"Suarez-Pinzon","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1074\/jbc.M406714200","article-title":"Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma","volume":"280","author":"Suzuki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1210\/endo.137.10.8828475","article-title":"The antilipolytic effects of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms","volume":"137","author":"Tebar","year":"1996","journal-title":"Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1073\/pnas.1006639107","article-title":"Paracrinology of islets and the paracrinopathy of diabetes","volume":"107","author":"Unger","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am. Stat."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"B46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/ajrccm.162.2.9908064","article-title":"Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat","volume":"162","author":"Yamada","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2009.28","article-title":"Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/biomedicines3010149","article-title":"Recent progress and advances in HGF\/MET-targeted therapeutic agents for cancer treatment","volume":"3","author":"Zhang","year":"2015","journal-title":"Biomedicines"},{"key":"B49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1362305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T07:04:41Z","timestamp":1713164681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1362305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":49,"alternative-id":["10.3389\/fmolb.2024.1362305"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2024.1362305","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"article-number":"1362305"}}